| NDC Code | 43203-852-47 |
|---|
| Package Description | 50 POUCH in 1 CASE (43203-852-47) / 1 BAG in 1 POUCH / 50 mL in 1 BAG |
|---|
| Product NDC | 43203-852 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Anticoagulant Citrate Dextrose A Acd-a |
|---|
| Non-Proprietary Name | Anticoagulant Citrate Dextrose A Acd-a |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | EXTRACORPOREAL |
|---|
| Start Marketing Date | 20110511 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | BA110057 |
|---|
| Manufacturer | Arteriocyte Medical Systems, Inc. |
|---|
| Substance Name | CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CITRATE, UNSPECIFIED FORM |
|---|
| Strength | .08; .245; .22 |
|---|
| Strength Unit | g/10mL; g/10mL; g/10mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
|---|